Information:
Fel:
ID
29711
Beskrivning
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response; ODM derived from: https://clinicaltrials.gov/show/NCT00758043
Länk
https://clinicaltrials.gov/show/NCT00758043
Nyckelord
Versioner (1)
- 2018-04-15 2018-04-15 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
15 april 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis C NCT00758043
Eligibility Hepatitis C NCT00758043
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C NCT00758043
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Hepatitis C untreated | Pharmaceutical Preparations Absent | Investigational New Drugs Absent | Pharmacotherapy Absent
Item
has not received any previous treatment with any approved or investigational drug or drug regimen for the treatment of hepatitis c
boolean
C0019196 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0013230 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0013216 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0332155 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0013230 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0013216 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Age
Item
male and female subjects, 18 to 70 years of age, inclusive
boolean
C0001779 (UMLS CUI [1])
Hepatitis C virus genotype determination | Hepatitis C, Chronic | HCV RNA Detectable
Item
genotype 1, chronic hepatitis c with detectable hcv rna.
boolean
C1533728 (UMLS CUI [1])
C0524910 (UMLS CUI [2])
C0369335 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
C0524910 (UMLS CUI [2])
C0369335 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
Laboratory Results Acceptable | Laboratory Procedures Acceptable | Physical Examination Acceptable
Item
screening laboratory values, tests, and physical exam within acceptable ranges
boolean
C1254595 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
C0022885 (UMLS CUI [2,1])
C1879533 (UMLS CUI [2,2])
C0031809 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
C1879533 (UMLS CUI [1,2])
C0022885 (UMLS CUI [2,1])
C1879533 (UMLS CUI [2,2])
C0031809 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Contraceptive methods Willing
Item
able and willing to follow contraception requirements
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,2])
Informed Consent | Protocol Compliance
Item
able to read and understand, and willing to sign the informed consent form and abide by the study restrictions.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
C0525058 (UMLS CUI [2])
Medical contraindication Pegasys | Medical contraindication Copegus
Item
subject has any contraindications to pegasys® or copegus® therapy
boolean
C1301624 (UMLS CUI [1,1])
C1176430 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1170183 (UMLS CUI [2,2])
C1176430 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1170183 (UMLS CUI [2,2])
Hepatic decompensation | Subject Cirrhotic
Item
evidence of hepatic decompensation in cirrhotic subjects
boolean
C1394798 (UMLS CUI [1])
C0681850 (UMLS CUI [2,1])
C0439686 (UMLS CUI [2,2])
C0681850 (UMLS CUI [2,1])
C0439686 (UMLS CUI [2,2])
Organ Transplantation
Item
history of organ transplant
boolean
C0029216 (UMLS CUI [1])
Medical condition Impact Patient safety
Item
history of, or any current medical condition which could impact the safety of the subject in participation in the study
boolean
C3843040 (UMLS CUI [1,1])
C4049986 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])
C4049986 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])